CEMI 1W Final 80% Fun Slide Running Corrective

10 ก.พ. 2023

test
Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Hauppauge, NY.

10 ก.พ. 2023

บันทึก

Last trade $0.28 terminal from private chart to $0.45 complete.

10 ก.พ. 2023

การซื้อขายยังคงดำเนินอยู่

10 ก.พ. 2023

บันทึก

First trade on CEMI yielded over 200%